1 “...HMG-CoA reductase inhibitors (statins) and fixed-dose combination products containing a statin...”

2 “...HMG-CoA reductase inhibitors (statins) and fixed-dose combination products containing a statin...”

3 “... Administration, causing a black box warning to be placed in each product's labeling. Several pharmacokinetic...”

4 “... Administration, causing a black box warning to be placed in each product's labeling. Several pharmacokinetic...”

5

6

7 “... multiple sclerosis. Evidence suggested that all 3 interferon beta-1 products and glatiramer reduced...”

8 “... multiple sclerosis. Evidence suggested that all 3 interferon beta-1 products and glatiramer reduced...”

9 “... were highest with amphetamine-based products but similar among methylphenidate products. Evidence...”

10 “... were highest with amphetamine-based products but similar among methylphenidate products. Evidence...”

11 “..., and kidneys that leads to the production of biologically active agents, including angiotensin I and II...”

12 “..., and kidneys that leads to the production of biologically active agents, including angiotensin I and II...”

13 “... in menopausal women. Estrogen production declines in women when ovarian function changes with aging or after...”

14 “... examining indoor tanning device use and sunscreen use may not be applicable to today's products due...”

15 “...-IgE medications, and combination products. The purpose of this review is to compare the benefits...”

16 “...-IgE medications, and combination products. The purpose of this review is to compare the benefits...”

17

18

19

20